We offer a novel topical treatment for ocular degeneration that restores neuronal function and vision with a simple eye drop.

After a venomous snake bite time is of the essence. We enable immediate bite treatment that delays the neurotoxic and tissue damaging effects of the venom, allowing time to seek help.

Our novel gene editing removes the immunogenicity of human Pluripotent Stem Cells upon implantation into human organs. We have chosen Type 1 Diabetes as the initial indication to demonstrate the potential of our platform.

Mastering surgical skills shouldn’t come at the cost of animals, high expenses, or limited training access. 3R SIMULATION reshapes animal surgical training with hyper-realistic simulators, offering a cost-effective, ethical, and accessible alternative to traditional methods. Our product enables professionals to hone skills anytime, anywhere, without sacrificing results. As demand for animal-free training grows, we are leading the shift towards a smarter, more responsible future in animal surgery education.

We offer a novel tool for antibiotic treatment. Our approach targets a broad spectrum of bacteria but eliminates the risk of evolving resistance by targeting a multitude of pathways.

Our data-driven platform integrates high-throughput analytics and AI for next-generation drug discovery. We leverage novel insights into the foundational biologic pathways of neurodegenerative diseases to discover, evaluate, and develop disease-modifying therapeutics for Alzheimer’s disease, frontotemporal dementia (FTD) , amyotrophic lateral sclerosis (ALS), and other degenerative diseases of the nervous system.

The SeVA platform is a composite AI device that can be effectively deployed in hospital, nursing homes and home settings. It has the capability to track a patient’s mental and physical state and signal early signs of risks such as delirium, falls or impending illness. It provides emotional support to the patient and their family by indulging in a natural conversation and facilitating their needs. When fully deployed, the product can serve as a platform which allays worry for people and their caregivers and will reduce healthcare costs by identifying the early signs of severe illness.

Safe Lactobacillus-based synthetic biologic as a colonization resistance agent of, and oral vaccine for, Clostridioides difficile infection (CDI).